Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Amcor ( (AMCR) ) has issued an announcement.
On May 1, 2026, Amcor plc’s board approved a change to the company’s fiscal year, shifting from a July 1–June 30 cycle to a calendar year running January 1–December 31, and designating July 1, 2026 to December 31, 2026 as a one-time transition period. The company’s first full calendar fiscal year will be the year ending December 31, 2027, with fiscal quarters aligned to calendar quarters, and Amcor plans to file a transition annual report for the abbreviated 2026 period while continuing to report under its current fiscal year framework until the end of 2026.
This realignment brings Amcor’s reporting calendar in line with standard market practice, which is likely to simplify comparisons for investors, analysts and regulators. It may also streamline internal planning and budgeting processes by synchronizing financial reporting with the calendar year, potentially enhancing transparency and consistency in the company’s external financial communications.
The most recent analyst rating on (AMCR) stock is a Buy with a $50.00 price target. To see the full list of analyst forecasts on Amcor stock, see the AMCR Stock Forecast page.
Spark’s Take on AMCR Stock
According to Spark, TipRanks’ AI Analyst, AMCR is a Neutral.
The score is held back primarily by weak technicals (bearish trend and negative MACD) and pressured profitability/returns alongside meaningful leverage. Offsetting factors are solid cash generation and a constructive earnings-call outlook driven by reaffirmed guidance and accelerating synergies, with the high dividend yield providing additional support despite a higher P/E.
To see Spark’s full report on AMCR stock, click here.
More about Amcor
Amcor plc is a global packaging company that designs and manufactures responsible packaging for food, beverage, pharmaceutical, medical, home and personal-care products. The company focuses on serving consumer and healthcare end markets worldwide, with operations structured and reported on a fiscal-year basis for regulatory and investor disclosure purposes.
Average Trading Volume: 5,649,834
Technical Sentiment Signal: Sell
Current Market Cap: $17.05B
See more insights into AMCR stock on TipRanks’ Stock Analysis page.